全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Two to five repeated measurements per patient reduced the required sample size considerably in a randomized clinical trial for patients with inflammatory rheumatic diseases

DOI: 10.1186/1756-0500-6-37

Keywords: Sample size, Statistical power, Clinical trial, Arthritis, General health questionnaire

Full-Text   Cite this paper   Add to My Lib

Abstract:

In a randomized controlled trial that evaluated the effects of a mindfulness-based group intervention for patients with inflammatory arthritis (n=71), the outcome variables Numerical Rating Scales (NRS) (pain, fatigue, disease activity, self-care ability, and emotional wellbeing) and General Health Questionnaire (GHQ-20) were measured five times before and after the intervention. For each variable we calculated the necessary sample sizes for obtaining 80% power (α=.05) for one up to five measurements.Two, three, and four measures reduced the required sample sizes by 15%, 21%, and 24%, respectively. With three (and five) measures, the required sample size per group was reduced from 56 to 39 (32) for the GHQ-20, from 71 to 60 (55) for pain, 96 to 71 (73) for fatigue, 57 to 51 (48) for disease activity, 59 to 44 (45) for self-care, and 47 to 37 (33) for emotional wellbeing.Measuring the outcomes five times rather than once reduced the necessary sample size by an average of 27%. When planning a study, researchers should carefully compare the advantages and disadvantages of increasing sample size versus employing three to five repeated measurements in order to obtain the required statistical power.Patient reported outcomes (PRO) are accepted as important outcome measures in rheumatology. In patients with rheumatic diseases the symptoms are fluctuating [1]. This has serious implications for sample sizes in clinical trials. Since the within-patient variation will be included in the total variation, this in turn will increase the standard deviation and finally require larger sample sizes.When planning a clinical trial, the researchers want to design it so that it has sufficient statistical power to detect a clinically relevant difference between groups [2]. When researchers draw conclusions, they want to avoid committing a Type II error, which basically means concluding that there is no difference when there is in fact a difference. Power is the probability of not making a

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413